Jeri Thomas Net Worth

Jeri Thomas biography

Jeri Thomas serves as Senior Vice President - Commercial of the Company. Ms. Thomas was senior vice president, strategic group planning at Harrison and Star, a healthcare marketing agency. From July 2016 to June 2017, Ms. Thomas was the managing director at JFB Consulting, a marketing consulting firm. From October 2014 to July 2016, Ms. Thomas served as senior vice president of the Surgical & Perioperative Care Business Unit at The Medicines Company, a biopharmaceutical company. Prior to The Medicines Company, Ms. Thomas was at Janssen Pharmaceuticals (a Johnson & Johnson company), a pharmaceutical company, from December 2001 to October 2014, where she held various senior leadership positions, including vice president, market strategy & access for Latin America, vice president, new business and new product planning, and director of marketing, analgesic franchise. Ms. Thomas obtained her Master of Business Administration in a dual program from the McDonough School of Business at Georgetown University and ESADE Business School

How old is Jeri Thomas?

Jeri Thomas is 58, she's been the Senior Vice President - Commercial of Liquidia Corp since 2018. There are 6 older and 12 younger executives at Liquidia Corp. The oldest executive at Liquidia Corp is Ralph Snyderman, 80, who is the Independent Director.

What's Jeri Thomas's mailing address?

Jeri's mailing address filed with the SEC is 419 DAVIS DRIVE, SUITE 100, , MORRISVILLE, NC, 27560.

Insiders trading at Liquidia Corp

Over the last 6 years, insiders at Liquidia Corp have traded over 16,750,945$ worth of Liquidia Corp stock and bought 12,456,625 units worth 100,694,400$ . The most active insiders traders include Forest Baskett、Scott D Sandell、Peter J Barris. On average, Liquidia Corp executives and independent directors trade stock every 18 days with the average trade being worth of 1,467,274$. The most recent stock trade was executed by Russell Schundler on 30 August 2024, trading 2,344 units of LQDA stock currently worth 23,792$.

What does Liquidia Corp do?

liquidia technologies is a biopharmaceutical company transforming the development of new therapies by precisely engineering drug particles. our proprietary print technology is a simple, elegant solution that solves common problems with drug delivery and efficacy. print technology is a scalable cgmp compliant process that creates particles and can apply to virtually any therapeutic area, molecule or route of administration. liquidia is bringing more efficient, controlled development capabilities to the industry while enhancing the safety and quality of products for patients. liquidia is advancing product candidates from its own pipeline. these initial product candidates, liq861 and liq865, apply the print technology to better drug delivery in inhaled and pain therapeutic areas, respectively. the print technology is also licensed with world-leading pharmaceutical companies that are developing future product candidates.

Liquidia Corp executives and stock owners

Liquidia Corp executives and other stock owners filed with the SEC include:

• Neal Fowler,
  Chief Executive Officer and Director
• Robert Lippe,
  Chief Operations Officer
• Robert A. Lippe,
  Chief Operations Officer
• Dr. Tushar Shah M.D.,
  Sr. VP of Product Devel. & Chief Medical Officer
• Damian deGoa,
  CEO & Director
• Stephen Bloch,
  Independent Chairman of the board
• Ralph Snyderman,
  Independent Director
• Raman Singh,
  Independent Director
• Seth Rudnick,
  Independent Director
• Arthur Kirsch,
  Independent Director
• Katherine Rielly-Gauvin,
  Independent Director
• Joanna Horobin,
  Independent Director
• Dr. Roger A. Jeffs Ph.D.,
  CEO & Director
• Tushar Shah,
  Chief Medical Officer
• Jeri Thomas,
  Senior Vice President - Commercial
• Robert Roscigno,
  Senior Vice President - Product Development
• Benjamin Maynor,
  Senior Vice President - Research & Development
• Steven Bariahtaris,
  Interim Chief Financial Officer
• Celia Reyes-Hoke,
  VP of People & Culture
• Scott Moomaw,
  Sr. VP of Commercial
• Jason Adair,
  Sr. VP of Corp. Devel. & Strategy
• Russell Schundler,
  Gen. Counsel & Corp. Sec.
• Jennifer Almond,
  Director of Investor Relations & Corp. Communications
• Michael Kaseta,
  Chief Financial Officer
• Dr. Ginger Denison,
  Co-Founder
• William R. Kenan Jr.,
  Co-Founder
• Partners Lpjohnson David Ed...,
  
• Ventures, Llceshelman Fredr...,
  
• Damian De Goa,
  Director
• Kevin K Gordon,
  President and CFO
• Edward T Mathers,
  Director
• Timothy Albury,
  SVP, Chief Accounting Officer
• Lt Ltd Zahir Fares Xeraya,
  
• Peter J Barris,
  10% owner
• M James Barrett,
  10% owner
• & Melinda Gates Foundation ...,
  
• Group Iv, Llc Wakefield,
  10% owner
• Group Iii, Llc Wakefield,
  10% owner
• Venture Investments Ltd Mor...,
  10% owner
• Product Development, Llc Wi...,
  
• Viii Lp Canaan Partners Vii...,
  
• Group Pte Ltdvorobyev Maxim...,
  
• Capital Spc Ltdal Wealth Pa...,
  
• Scott D Sandell,
  10% owner
• Patrick J Kerins,
  10% owner
• Forest Baskett,
  10% owner
• East Ltd Bathurst Enterpris...,
  
• Plc Gsk,
  
• Enterprise Associates 12, L...,
  
• Of North Carolina At Chapel...,
  10% owner
• Capital Ii, Lp Sovereign's,
  10% owner
• Revelation Healthcare Fund ...,
  
• Family Credit Llc Series D ...,
  
• Mutual Holdings, Inc. Medical,
  10% owner
• Arthur Ma.M. Pappas Life Sc...,
  
• Ltd Bathurst Enterprises Lt...,
  
• David Edward Johnson,
  Director
• Shawn Glidden,
  VP,Legal Affairs and Secretary
• Richard D Katz,
  Chief Financial Officer
• David Edward Caligan Partne...,
  
• Michael Kaseta,
  CFO and COO
• Florina Krawchick,
  SVP, Human Resources
• Rajeev Saggar,
  Chief Medical Officer
• Scott Moomaw,
  Chief Commercial Officer
• Roger Jeffs,
  Chief Executive Officer
• Russell Schundler,
  General Counsel
• Paul B Manning,
  Director
• Jason Adair,
  Chief Business Officer